Thus, miR-153 and miR-205 have been identified as potential therapeutic targets in PD, as miR-153 and miR-205 mimic targeting a-synuclein and LRRK2 protein in PD [122,123]. This evidence concerns the gene LRRK2 and Parkinson disease.